Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs13004470 | chr2:242511083 | C/T | 7.69E-11 | 174 | 25.87 | 24.07 | 10.3 | KM Plot |
PCPG | rs13024132 | chr2:24344628 | C/G | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs13028767 | chr2:24335554 | T/G | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs13054581 | chr22:21283074 | T/C | 8.52E-5 | 176 | 12.93 | 31.2 | 25.2 | KM Plot |
PCPG | rs13058817 | chr3:53024139 | C/T | 6.73E-6 | 176 | 25.28 | 26.05 | 11.78 | KM Plot |
PCPG | rs13060044 | chr3:80546587 | C/T | 6.02E-5 | 178 | 19.87 | 24.03 | 27.2 | KM Plot |
PCPG | rs13060063 | chr3:80583738 | G/T | 6.33E-5 | 177 | 19.53 | 24.53 | 27.4 | KM Plot |
PCPG | rs13069006 | chr3:52973305 | G/C | 6.56E-6 | 176 | 25.17 | 26.57 | 11.78 | KM Plot |
PCPG | rs13072395 | chr3:52980573 | T/C | 6.73E-6 | 176 | 25.08 | 30.52 | 11.78 | KM Plot |
PCPG | rs13072457 | chr3:53102389 | G/A | 9.74E-6 | 173 | 25.08 | 25.53 | 11.78 | KM Plot |
PCPG | rs13077864 | chr3:136609838 | T/C | 0.000423 | 172 | 24.5 | 31.47 | 22.15 | KM Plot |
PCPG | rs13078405 | chr3:80600837 | T/C | 0.000136 | 176 | 19.87 | 23.53 | 27.4 | KM Plot |
PCPG | rs13078834 | chr3:52984770 | G/T | 6.73E-6 | 176 | 25.08 | 30.52 | 11.78 | KM Plot |
PCPG | rs13078962 | chr3:39167458 | T/C | 7.83E-7 | 178 | 25.87 | 20.47 | 24.72 | KM Plot |
PCPG | rs13078971 | chr3:53103645 | G/C | 9.74E-6 | 173 | 25.08 | 25.53 | 11.78 | KM Plot |